AKT1 and cancer: On the contrary, pretreatment with the JAK2/STAT3 pathway inhibitor AG490 or stattic inhibited propofol-induced AKT phosphorylation [5, 46], suggesting that the link between PI3K and STAT3 pathways is significant in human cancers.